about
Advances in non-surgical management of primary liver cancer.Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.Management of hepatocellular carcinoma: an overview of major findings from meta-analysesMedical treatment of hepatocellular carcinoma.Evolution of systemic therapy of advanced hepatocellular carcinoma.Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions.
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Tamoxifen for hepatocellular carcinoma
@ast
Tamoxifen for hepatocellular carcinoma
@en
Tamoxifen for hepatocellular carcinoma
@en-gb
Tamoxifen for hepatocellular carcinoma
@nl
type
label
Tamoxifen for hepatocellular carcinoma
@ast
Tamoxifen for hepatocellular carcinoma
@en
Tamoxifen for hepatocellular carcinoma
@en-gb
Tamoxifen for hepatocellular carcinoma
@nl
prefLabel
Tamoxifen for hepatocellular carcinoma
@ast
Tamoxifen for hepatocellular carcinoma
@en
Tamoxifen for hepatocellular carcinoma
@en-gb
Tamoxifen for hepatocellular carcinoma
@nl
P2093
P3181
P1476
Tamoxifen for hepatocellular carcinoma
@en
P2093
Anna K Nowak
Gordana Culjak
Martin R Stockler
Michael Findlay
P3181
P356
10.1002/14651858.CD001024.PUB2
P577
2004-07-19T00:00:00Z